Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
110 results about "Dammarane" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Dammarane is a tetracyclic triterpene found in sapogenins (forming triterpenoid saponins) like those of ginseng (ginsenosides: panaxatriol and protopanaxadiol). Compounds of the series were first isolated from and named after dammar resin, a natural resin from tropical trees of the Dipterocarp family.
Use of dammarane-type triterpene derivatives
The invention provides a use of dammarane-type triterpene derivatives represented by general formula I or pharmaceutically acceptable salts thereof, and a use of a medicinal composition containing the derivatives or the pharmaceutically acceptable salts thereof, and a plant extract product. The dammarane type triterpene derivatives, the medicinal composition and the plant extract product can activate AMPKalpha2beta1gamma1 at the molecular level, and can be used to prepare AMPK micromolecule activators in order to prepare medicines for preventing or treating AMPK related diseases.
Owner:SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
Compounds for treating alzheimer's disease and for inhibiting beta-amyloid peptitde production
The present invention provides compositions and methods for treating and preventing Alzheimer's disease by administering to a subject an effective amount of a dammarane or ginsenoside compound. The invention also provides compositions and methods for modulating beta-amyloid protein production, including Abeta42 in a cell. The invention further provides compositions and methods for treating and preventing neurodegeneration by administering to a subject an effective amount of a dammarane or ginsenoside compound. Additionally, the invention provides kits for use in treating and / or preventing Alzheimer's disease and neurodegeneration, as well as for reducing the production of beta-amyloid protein.
Owner:THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK
Detection method for dammarane type four-ring triterpenoid saponin
The invention relates to a method for detecting dammarane tetracyclic triterpenoid saponin and secondary aglycone. The inventive method uses high-efficiency liquid color spectrum-mass spectrum coupled device, wherein the conditions of high-efficiency liquid color spectrum comprises: color spectrum column is ODSC18 column; the column temperature is 20-38Deg. C; the conditions of mass spectrum comprise: the ion source is Turbo Ionspray source; the ejecting voltage is 3000-5000V; the Tem is 250-300Deg. C; the detector uses triplicate four-electrode serial mass spectrum detection and positive ion detection; the scanning method uses multi-reaction detection (MRM); CE is 17-36V; DP is 8-110V; the ion detection comprises: processing impact induce dissociation on the quasi-molecule ion peak of said saponin of first-stage scanning mass spectrum, to obtain the second-stage fragment ion; and uses multi-reaction detection (MRM) scanning method to analyze the ion reaction quantitatively, to represent the blood drug density of monomer saponin and secondary aglycone.
Owner:INST OF MEDICINAL PLANT DEV CHINESE ACADEMY OF MEDICAL SCI
Compounds for treating Alzheimer's disease and for inhibiting beta-amyloid peptitde production
InactiveUS20050245465A1Low production of AβLower Level RequirementsOrganic active ingredientsBiocideAmyloidDisease cause
The present invention provides compositions and methods for treating and preventing Alzheimer's disease by administering to a subject an effective amount of a dammarane or ginsenoside compound. The invention also provides compositions and methods for modulating beta-amyloid protein production, including Aβ42 in a cell. The invention further provides compositions and methods for treating and preventing neurodegeneration by administering to a subject an effective amount of a dammarane or ginsenoside compound. Additionally, the invention provides kits for use in treating and / or preventing Alzheimer's disease and neurodegeneration, as well as for reducing the production of beta-amyloid protein.
Owner:SKKU FOUND FOR COLLABORATION
Dammarane type triterpenoid saponin compound, preparation method thereof and application thereof in preparation of anti-inflammatory drugs
ActiveCN110746474AReduce expressionGood anti-inflammatory activityOrganic active ingredientsSugar derivativesSilica columnChemical compound
The invention discloses a dammarane type triterpenoid saponin compound, a preparation method thereof and application thereof in preparation of anti-inflammatory drugs. The dammarane type triterpenoidsaponin compound is obtained by separation of cyclocarya paliurus leaves. The preparation method comprises steps of S1, extracting the cyclocarya paliurus leaves by using an alcohol solvent to obtainan extract, wherein the mass ratio of the cyclocarya paliurus leaves to the alcohol solvent is 1: (10-15); S2, separating the extract prepared in the step S1) sequentially by using silica gel column chromatography, MCI gel column choromatography, reversed-phase column choromatography, gel column choromatography and preparation type high performance liquid chromatography to obtain the compound. Thenew compound prepared by the method can suppress release of NO, TNF-alpha, PGE2 and IL-6 in LPS induced RAW264.7 cells, can reduce expression of iNOS, COX-2 and NF-KB / P65 protein, can take on good anti-inflammatory activity and can be used for developing related anti-inflammatory drugs.
Owner:GUANGXI NORMAL UNIV
Anti-herpes simplex virus I-form medicament composition and uses thereof
InactiveCN101322714AOrganic active ingredientsDigestive systemStructural formulaHerpes simplex disease
The invention relates to a pharmaceutical composition with dammarane-type tetracyclic triterpene compound as an active component and an application thereof to the pharmaceutical field. Panax notoginseng is separated to obtain three dammarane-type tetracyclic triterpene compounds as shown in the following structural formula, in vitro pharmacological experiments show that the pharmaceutical composition has good in vitro inhibitory activity for herpes simplex virus type I and can be applied to the preparation of medicines for resisting herpes simplex virus type I and is used for treating herpetic keratitis, encephalitis, pneumonia, ulcerative stomatitis, blister and the like caused by herpes simplex virus type I.
Owner:KUNMING INST OF BOTANY - CHINESE ACAD OF SCI
Saponin compounds or pharmaceutically acceptable salts thereof, compositions, and preparation method of saponin compounds or pharmaceutically acceptable salts therof, and application of saponin compounds or pharmaceutically acceptable salts thereof and compositions
ActiveCN111187331ANovel side chain structureActiveOrganic active ingredientsAntipyreticSide chainPharmaceutical medicine
The invention relates to saponin compounds or pharmaceutically acceptable salts thereof, compositions, and a preparation method of the saponin compounds or the pharmaceutically acceptable salts thereof, and application of the saponin compounds or the pharmaceutically acceptable salts therof and the compositions. Chemical components of gynostemma pentaphylla are subjected to systematic extraction,separation and purification by using various column chromatographic separation methods, and the compound having a dammarane tetracyclic triterpenoid structures and containing a glycosyl group in a side chain is obtained through separation. The compounds obtained by separation according to a technical scheme in the invention have anti-inflammatory, anti-tumor, antioxidant and lipid-lowering activities and the like.
Owner:TIANJIN UNIV OF TRADITIONAL CHINESE MEDICINE
Novel dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
This invention relates to a group of novel sapogenins, their use in anti-cancer applications, and to a process for their production. More particularly, this invention pertains to a novel group of dammarane sapogenins, PAM-120, PBM-110 and PBM-100 (the dammarance sapogenine structure is specifically clean of any sugar moieties (glycons) at any position and hydroxyl at C-20) and PAN-20 and PAN-30 (the dammarance sapogenin structure has sugar moieties but is free of hydroxyl at C-20), obtained by chemical cleavage of dammarane saponins. The invention also includes a novel application of the said sapogenins for anti-cancer treatment by using them separately or together, and / or jointly with other drugs, as well as to the process of producing these novel sapogenins. Said novel dammarane sapogenins show surprising anti-cancer effect when applied, particularly against multi-drug resistant cancers.
Owner:PANAGIN PHARMA INC
Dammarane sapogenins, their use as anti-cancer agents, and a process for producing same
InactiveUS6888014B2Unexpected and superior activitySurprising anti-cancer effectBiocideOrganic active ingredientsAnticarcinogenSapogenin
This invention relates to a group of novel sapogenins, their use in anti-cancer applications, and to a process for their production. More particularly, this invention pertains to a novel group of dammarane sapogenins, PAM-120, PBM-110 and PBM-100 (the dammarance sapogenine structure is specifically clean of any sugar moieties (glycons) at any position and hydroxyl at C-20) and PAN-20 and PAN-30 (the dammarance sapogenin structure has sugar moieties but is free of hydroxyl at C-20), obtained by chemical cleavage of dammarane saponins. The invention also includes a novel application of the said sapogenins for anti-cancer treatment by using them separately or together, and / or jointly with other drugs, as well as to the process of producing these novel sapogenins. Said novel dammarane sapogenins show surprising anti-cancer effect when applied, particularly against multi-drug resistant cancers.
Owner:PANAGIN PHARMA INC
Application of 20(S)-ginsenoside Rh2 compound in preparing antidepressant medicament
The invention relates to application of a 20(S)-ginsenoside Rh2, namely 3-O-beta-D-glycopyranoside-dammarane-24-alkenyl-3beta, 12beta, 20(S)-triol compound in the field of pharmacy. The compound can effectively confront reserpine related ptosis or akinesia, L-5-HT related mouse tremble, mouse suspension tail or forced swimming acquired desperation and depression and enhance levodopa behavioral effects under test dose, and has no excitation or inhibition function on central pivot. The safety research shows that the compound has high safety, does not influence the central nervous system, cardiovascular system and respiratory system, and has no mutagenesis function. The compound has high safety and good antidepressant function under the test dose, and the action mechanism of the compound can block the reuptake of NA and DA transmitter so as to increase the concentration correlation of two transmitters of synapse and clearance; and the compound can be used for treating depression.
Owner:上海药谷药业有限公司
Medical use of a pair of ginseng saponin aglycones and their mixture
InactiveCN101234117AGrowth inhibitionPrevent proliferationOrganic active ingredientsAntineoplastic agentsSide effectWilms' tumor
The invention belongs to a filed of medicine technology, which relates to a novel pair of panaxsapogenol and a medical application of a mixture thereof. The pair of compounds are 20(R)-25-methoxyl-dammarane-3beta, 12beta, 20-triol(25Rmdt for short) and 20(S)-25-me-thoxyl-dammarane-3beta, 12beta, 20-triol(25Smdt for short). The 25Rmdt and 25Smdt and the mixture thereof have the antitumor activities of inhibiting the growth and multiplication of a plurality of tumor cells, inducing the differentiation and withering of tumor cells, inhibiting the generation of tumor angiogenic blood vessels, inhibiting the invasion and transfer of tumors, enhancing the body immunity and reducing the toxic and side effects of chemotherapeutic drugs, which is substantially used for treating malignant tumors, with a total effective dosage of 1-100mg / kg / d.
Owner:CHIA TAI TIANQING PHARMA GRP CO LTD +1
Method for preparing 20(R)-25-hydroxy-dammarane type-3beta,12beta,20-triols
ActiveCN102093453AGood antitumor activityInhibition of tumor cells is excellentSteroidsNMR - Nuclear magnetic resonanceProtopanaxadiol
The invention provides a method for preparing protopanoxadiol derivatives of a formula below, namely 20(R)-25-hydroxy-dammarane type-3beta,12beta,20-triols[abbreviated as 20(R)-25-OH-PPD]. The protopanoxadiol derivatives are obtained by hydrolyzing total ginsenoside, wherein the method for hydrolyzing the total ginsenoside comprises a basic hydrolysis process, an acid hydrolysis process I and an acid hydrolysis process II. The structure of the 20(R)-25-hydroxy-dammarane type-3beta,12beta,20-triols is determined by nuclear magnetic resonance spectrum. The method is high in yield and purity, ensures stable product quality and can realize industrial production and can meet the needs for development of new antitumor medicines.
Owner:辽宁新中现代医药有限公司
Method for preparing 20(R)-25-hydroxy-dammarane type-3beta,12beta,20-triol
InactiveCN101121741AMeet development needsGood antitumor activityMicroorganism based processesFermentationProtopanaxadiolAcid hydrolysis
The invention provides a preparation method of the original protopanaxadiol derivative with the structure as 20 (R)-25-hydroxy-dammarane-3beta, 12beta, 20- triol [for short 20 (R)-25-OH-PPD]. The silica gel chromatography and the total ginsenoside hydrolysis are used to make the original protopanaxadiol derivative; therein, the ginsenoside hydrolysis includes the alkali water hydrolysis the acid hydrolysis I and the acid hydrolysis II. The NMR spectrum is used to determine the structure. The method is of the high collection rate, the high purity and the stable quality of the products; the invention can realize the industrial production, and can meet the development requirements of the novel anti-tumor drugs.
Owner:辽宁新中现代医药有限公司
Dammarane aglycon compound and application thereof
InactiveCN102125571AHigh purity of ingredientsImprove quality controllabilityOrganic active ingredientsBlood disorderOral medicationBone marrow suppression
The invention relates to a dammarane aglycon compound and application thereof, in particular to application of oral administration and injection preparations which are prepared by a single dammarane aglycon compound prepared by basic hydrolysis by utilizing the particular patent technology of the Pegasus Pharmaceuticals Group of Canada by adopting Asian ginseng stem and leave saponin or prepared in the way that the dammarane aglycon compound is matched with other medically permissive auxiliary materials in prevention and treatment on bone marrow suppression caused by different chemotherapy and radiotherapy.
Owner:TIANMA PHARMA GROUP +1
Dammarane triterpene derivative, pharmaceutical composition thereof, and applications of dammarane triterpene derivative in pharmacy
The invention discloses a dammarane triterpene derivative represented by formula (I); a pharmaceutical salt thereof; a preparation method of the dammarane triterpene derivative; a pharmaceutical composition containing the dammarane triterpene derivative as an active ingredient; applications of the dammarane triterpene derivative, the pharmaceutical salt, and the pharmaceutical composition in preparation of medicines used for treating or preventing obesity, diabetes, hypertension, cardiovascular and cerebrovascular diseases, and related metabolic diseases; and applications of the dammarane triterpene derivative, the pharmaceutical salt, and the pharmaceutical composition in preparation of 11<beta>-HSD1 inhibitor.
Owner:KUNMING INST OF BOTANY - CHINESE ACAD OF SCI
Pseudoginsenoside G1 and extraction method and medicinal applications thereof
ActiveCN101948499AReduce adhesionReduce aggregationOrganic active ingredientsSteroidsEpoxyMyocardial ischaemia
The invention relates to a pseudoginsenoside G1 and an extraction method and medicinal applications thereof, belonging to a new compound and medicinal applications thereof. The method comprises the following steps: taking Red American ginseng to grind, adding 3-7 times of 70-95% ethanol to heat and reflux for extraction, wherein each extraction requires 2-4 hours and 3-6 times of extractions are needed; mixing the extracting solutions, recovering the solvent till dry; adopting the silica gel column chromatography to treat ethanol extract, wherein the eluent is CHCl3-MeOH and the weight ratio is 80-110:20-40; adopting the C-18 reversed phase column chromatography to treat, wherein the eluent is MeOH-H2O and the weight ratio is 50-70:30-50; and using the mixture of methanol and water in a weight ratio of 1:2-5 to perform crystallization and obtain the pseudoginsenoside G1. The chemical name of the product is 3-O-[beta-D-glucopyranosyl-(1-2)-beta-D-glucopyranosyl]-dammarane-12-one-20S,24R-epoxy-3beta,25-diol. The pseudoginsenoside G1 can be used in the preparation of medicines for curing myocardial infarction, resisting myocardial ischemia and reducing the adhesion and aggregation of platelets.
Owner:吉林圣亚医药科技有限公司
Method for preparing composite with antineoplastic activity by panoxadiol
ActiveCN101538305AEasy to separate and purifyMild conditionsOrganic active ingredientsSteroidsProtopanaxadiolTriol
The invention discloses a method for preparing a composite with antineoplastic activity by panoxadiol, which can prepare a plurality of composites with dammarane mother nuclei, wherein two groups of protopanoxadiol derivatives with obvious antineoplastic activity are contained; the invention also discloses a preparation method of the composites, wherein names of the composites are respectively as follows: 20(S), 20(R)-dammarane-3 beta, 12 beta, 20, 25-tetrol, 20(S), 20(R)-25-methoxyl group (or oxyethyl group)-dammarane-3 beta, 12 beta, 20-triol, 20(S), 20(R)-20-methoxyl group (or oxyethyl group)-dammarane-3 beta, 12 beta, 25-triol and 20(S), 20(R)-22, 25-dimethoxy (or diethoxy)-dammarane-3 beta, 12 beta-diol. The invention is simple and easy to operate and has moderate condition, easy product separation and higher yield coefficient. In the general formula of 20(S) and 20(R)-dammarane-diol derivant, R1 and R2 can be OH and CH3.
Owner:SHENYANG PHARMA UNIVERSITY
Dammarane triterpenoid glycoside compound as well as preparation method and application thereof
The invention discloses dammarane triterpenoid glycoside compounds as well as a preparation method and application thereof. The dammarane triterpenoid glycoside compounds are specifically three compounds which are separated from a rubiaceae rubia plant, namely Mycephala sinensis (Hemsl.) Craib, and the structural formula of the dammarane triterpenoid glycoside compounds is shown in the specification. Tests show that the dammarane type triterpenoid saponin with the structure shown in the formula 2 has sweetness, the sweetness of the dammarane type triterpenoid saponin is about 200 times that ofcane sugar, and the dammarane type triterpenoid saponin can be used as a sweetening agent and applied to various industries such as food and medicines.
Owner:GUANGXI INST OF BOTANY THE CHINESE ACAD OF SCI
Dammarane type triterpene compound and preparation method and application thereof
InactiveCN103012537AHigh purityGood benefitOrganic active ingredientsAntipyreticSelf formingEconomic benefits
The invention relates to a dammarane type triterpene glycoside compound obtained by extracting and separating from tetraploid gynostemma pentaphyllum, and a preparation method and application of the dammarane type triterpene glycoside compound. The compound, and optical isomers, medicinal salt derivatives and solvates of the compound have a purpose of preparing an anti-inflammatory drug, can be applied in self-forms, and can also be applied by forming drug compositions with acceptable carriers in pharmacy; the preparation method is simple and easy to operate; and the obtained compound is high in purity, and has a good economic benefit and an industrial application prospect.
Owner:SHANGHAI JIAO TONG UNIV
Camellia nitidissima saponin A, and preparation method and antitumor application thereof
InactiveCN104262445AHigh purityImprove ultrasonic extraction rateOrganic active ingredientsGlycoside steroidsD-GlucopyranoseMethyl group
The invention relates to a new Camellia nitidissima saponin A compound separated from Camellia nitidissima and a preparation method thereof, and application of the compound in tumor resistance. The dammarane saponin new compound is separated from Camellia nitidissima. The new compound is named (3beta,6alpha,12beta)-3,6,12-trihydroxydammaryl-24-alkenyl-20-methyl-2-O-beta-D-glucopyranosyl-(2->1)-O-beta-D-glucopyranosyl-(2->1)-O-alpha-L-pyranylrhamnosido[(3beta,6alpha,12beta)-3,6,12-trihydroxydammar-24-en-20-yl-2-O-beta-D-glucopyranosyl-(2->1)-O-beta-D-glucopyranosyl-(2->1)-O-alpha-L-Rhamnopyranoside]. A CCk-8 process is utilized to carry out antitumor activity detection on the new compound; and the experimental result indicates that the compound has the activities for inhibiting human lung cancer BeL-7402 cells, SMMC-7721 and the like from growth.
Owner:GUANGXI ZHUANG AUTONOMOUS REGION CENT FOR ANALYSIS & TEST RES +3
Method for producing low-polarity ginsenoside
InactiveCN105622701AControllable outputComponents are easy to controlGlycoside steroidsCatalytic decompositionHydroxy compound
The invention discloses a method for producing low-polarity ginsenoside. The method comprises the following steps: performing catalytic decomposition of the raw materials: a ginsenoside-containing plant, a tissue culture of the plant, an extract of the plant and / or natural ginsenoside; and heating and separating to obtain the low-polarity ginsenoside. By adopting the ginseng processing method disclosed by the invention, 25-hydroxyl dammarane and 25-dammarene can be produced; and by carefully controlling the catalytic decomposition process, the output and composition of the extracted ginsenoside are controllable, and the yield of the target product extracted from the raw materials such as treated ginseng is high.
Owner:JILIN UNIV
Compounds and their preparation for the treatment of Alzheimer's disease by inhibiting beta-amyloid peptide production
InactiveUS20060014729A1Inhibit productionOrganic active ingredientsSteroidsMedicineNeuro-degenerative disease
The present invention provides novel dammarane compounds, compositions (e.g., pharmaceutical compositions) comprising the dammarane compounds, and methods for the synthesis of these dammarane compounds. Additionally, the present invention provides methods for inhibiting beta-amyloid peptide production and methods for treating or preventing a pathological condition, particularly, neurodegeneration diseases (e.g., Alzheimer's disease), using these dammarane compounds.
Owner:LANDRY DONALD +2
Anti-hepatic fibrosis medical application of dammarane type sapogenin
The invention belongs to the technical field of medicines and relates to an anti-hepatic fibrosis medical application of dammarane type sapogenin 20(R)-25-methoxy-dammarane-3beta,12beta,20-triol and 20(R)-25-hydroxyl-dammarane-3beta,12beta,20-triol (which are called as 25-OCH3-PPD and 25-OH-PPD for short). Study shows that 25-OCH3-PPD and 25-OH-PPD can be used for reducing expression of alpha-SMA, TGF-beta and TIMP-1, improving caspase-3 level and increasing signal paths for NF-kappaB redistribution and generation of Bcl-2 proteins in hepatic stellate cells, and the hepatic stellate cells are reversed to be in a resting state, so that hepatic fibrosis is reversed, and 25-OCH3-PPD and 25-OH-PPD can be used for preparing a medicine for treating the hepatic fibrosis.
Owner:SHENYANG PHARMA UNIVERSITY
3,4-dammarane tetracyclic triterpenoid compound as well as extraction method and application thereof
InactiveCN111100175AIncrease consumptionIncrease contentOrganic active ingredientsNervous disorderPancreatic hormoneFatty acid
The invention discloses a 3,4-dammarane tetracyclic triterpenoid compound with the structural formula shown in formulas (1)-(4). The invention further discloses an extraction method and application ofthe 3,4-dammarane tetracyclic triterpenoid compound. The 3,4-dammarane tetracyclic triterpenoid compoundcan significantly increase the consumption of insulin resistance adipocyte glucose, inhibit generation of IR adipocyte FFA, reduce the content of free fatty acid in cells and activate PPAR<gamma> to a certain extent.
Owner:CENT SOUTH UNIV +2
Process for producing a pair of novel ginsengenin and its compound body, and preparations thereof
The invention pertains to the field of medical technology, which relates to a pair of new ginsengenins, the preparation method of the mixture thereof (raceme) and a novel anti-tumor preparation which contains the compounds as active ingredients. The names of the pair of compounds are 20(R)-25-methoxyl-dammarane-3 Beta, 12 Beta, 20-triol(known as 25Rmdt for short) and 20(S)-25-methoxy-dammarane-3 Beta, 12 Beta, 20-triol(known as 25Smdt for short). The compounds of the invention can be prepared by adopting acid hydrolysis method, alkaline hydrolysis method and synthesis method, and the preparation method is simple and feasible. The 25Rmdt, the 25Smdt, the mixture (raceme) and a pharmaceutically acceptable carrier can be made into the clinical feasible various formulations, studies prove that: the compounds and the preparations have significant anti-tumor effects, and can be made into any medicinal and health care formulation for the treatment of different cancers and be mainly applied in the prevention and the treatment of malignant tumors with the broad application prospect.
Owner:CHIA TAI TIANQING PHARMA GRP CO LTD
Application of dammarane triterpenes derivative and drug composition containing dammarane triterpenes derivative
InactiveCN101530419APrevent proliferationAntiproliferative activityOrganic active ingredientsDigestive systemMedicineApoptosis
The invention provides the application of a dammarane triterpenes derivative with the structure shown as the following formula (I), a drug composition containing the dammarane triterpenes derivative, and application thereof. The dammarane triterpenes derivative and the drug composition which can induce the apoptosis of hepatic stellate cells can be used for preparing drugs for preventing or treating hepatic fibrosis and hepatocirrhosis.
Owner:SHANGHAI INST OF MATERIA MEDICA CHINESE ACAD OF SCI
20(S) or 20(R)-dammarane-3 beta,12 beta, 20,25-tetraalcohol derivative, its salt and use thereof
InactiveCN101250212AHigh activityLow toxicityOrganic active ingredientsAntiviralsAnti virusDrug compound
The invention provides a 20(S) / 20(R)-dammarane-3beta, 12beta, 20, 25-tetraol derivative, relative salt and anti-tumor application, belonging to medical technical field, wherein the 20(S) / 20(R)-dammarane-3beta, 12beta, 20, 25-tetraol derivative and relative salt are respresented as below, the 20(S) / 20(R)-dammarane-3beta, 12beta, 20, 25-tetraol derivative and relative salt can be combined with medical acceptable carrier into drug compound, to prepare anti-virus and anti-tumor drugs. The 20(S) / 20(R)-dammarane-3beta, 12beta, 20, 25-tetraol derivative and relative salt have stronger anti-viruse and anti-tumor activity than dammarane-3beta, 12beta, 20, 25-tetraol, which can improve the activity of other anti-virus and anti-tumor drugs and reduce the toxicity.
Owner:SHENYANG PHARMA UNIVERSITY
C3, C6, C17-trisubstituted dammarane type triterpenoid saponin derivative, pharmaceutical composition thereof and applications of derivative in pharmacy
The invention provides a dammarane type triterpenoid saponin derivative represented in a general formula I, pharmaceutical composition adopting the dammarane type triterpenoid saponin derivative as an active ingredient, and applications of the dammarane type triterpenoid saponin derivative in preparation of drugs for treating neurological diseases and Alzheimer's disease. R1 in the formula I is hydrogen or glycosyl, R2 is hydrogen or glycosyl, and R3 is the C-20-C-27 site of a dammarane type triterpenoid C17-site side chain.
Owner:KUNMING INST OF BOTANY - CHINESE ACAD OF SCI
Anti-coxsackie medicament composition and medicine use thereof
The invention relates to a pharmaceutical composition with dammarane-type tetracyclic triterpene compound ginsenoside Rh4 as shown in the following structural formula and 20(S)-protopanaxatriol as the active components and the application thereof to the pharmaceutical field. The in vitro pharmacological experiments show that the pharmaceutical composition has good in vitro inhibitory activity for coxsackie B3 virus and can be used for treating viral myocarditis caused by coxsackie B3 virus.
Owner:KUNMING INST OF BOTANY - CHINESE ACAD OF SCI
Cultivation method of novel dammarane-type ginsenoside-containing paddy rice variety
InactiveCN103333914AVector-based foreign material introductionAngiosperms/flowering plantsBiotechnologyEnzyme Gene
The invention discloses a cultivation method of a novel dammarane-type ginsenoside-containing paddy rice variety and belongs to the field of genetic engineering. The breeding method is characterized in that a full-length cDNA of a gene of a dammarenediol synthetase as a key enzyme of dammarane-type ginsenoside biosynthesis is constructed to double-T-DNA plant expression vectors; the constructed product is subjected to genetic transformation in paddy rice; and through screening cultivation, the novel dammarane-type ginsenoside-containing paddy rice variety is obtained. A test proves that the novel dammarane-type ginsenoside-containing paddy rice variety comprises 0.020% of 20(S)-protopanoxadiol (PPD) and 0.173% of 20(S)-protopanaxatriol (PPT). The cultivation method can be used for cultivation of high-quality ginseng rice varieties containing dammarane-type ginsenoside, can improve a health care value of rice as a main food of a human body, can widen a ginsenoside source, can alleviate the scarcity of a ginsenoside drug source, and has a good application prospect.
Owner:FUJIAN CHAODA GROUP
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com